136 related articles for article (PubMed ID: 28418283)
21. Ghrelin and adipokines as circulating markers of disease activity in patients with Takayasu arteritis.
Yilmaz H; Gerdan V; Kozaci D; Solmaz D; Akar S; Can G; Gulcu A; Goktay Y; Sari I; Birlik M; Akkoc N; Onen F
Arthritis Res Ther; 2012 Dec; 14(6):R272. PubMed ID: 23259466
[TBL] [Abstract][Full Text] [Related]
22. High mobility group box 1 levels in large vessel vasculitis are not associated with disease activity but are influenced by age and statins.
de Souza AW; van der Geest KS; Brouwer E; Pinheiro FA; Oliveira AC; Sato EI; Andrade LE; Bijl M; Westra J; Kallenberg CG
Arthritis Res Ther; 2015 Jun; 17(1):158. PubMed ID: 26062541
[TBL] [Abstract][Full Text] [Related]
23. NMR-Based Serum Metabolomics Discriminates Takayasu Arteritis from Healthy Individuals: A Proof-of-Principle Study.
Guleria A; Misra DP; Rawat A; Dubey D; Khetrapal CL; Bacon P; Misra R; Kumar D
J Proteome Res; 2015 Aug; 14(8):3372-81. PubMed ID: 26081138
[TBL] [Abstract][Full Text] [Related]
24. Determinants of arterial stiffness in female patients with Takayasu arteritis.
Salles Rosa Neto N; Levy-Neto M; Tolezani EC; Bonfá E; Bortolotto LA; Pereira RM
J Rheumatol; 2014 Jul; 41(7):1374-8. PubMed ID: 24882839
[TBL] [Abstract][Full Text] [Related]
25. Association of abnormal lipid spectrum with the disease activity of Takayasu arteritis.
Wang X; Chen B; Lv N; Liu Q; Dang A
Clin Rheumatol; 2015 Jul; 34(7):1243-8. PubMed ID: 25388645
[TBL] [Abstract][Full Text] [Related]
26. Matrix metalloproteinases as novel disease markers in Takayasu arteritis.
Matsuyama A; Sakai N; Ishigami M; Hiraoka H; Kashine S; Hirata A; Nakamura T; Yamashita S; Matsuzawa Y
Circulation; 2003 Sep; 108(12):1469-73. PubMed ID: 12952836
[TBL] [Abstract][Full Text] [Related]
27. Serum C-reactive protein level but not its gene polymorphism is associated with Takayasu arteritis.
Cheng Y; Dang A; Lv N; Gao Q; Chen B; Liu G
Clin Rheumatol; 2016 Mar; 35(3):673-8. PubMed ID: 24894103
[TBL] [Abstract][Full Text] [Related]
28. [Relationships between the levels of serum 25-hydroxyvitamin D and interleukin-6 in patients with Takayasu's arteritis].
Liao H; Pan LL; Du J; Wang T
Zhonghua Yi Xue Za Zhi; 2018 Nov; 98(43):3509-3512. PubMed ID: 30481900
[No Abstract] [Full Text] [Related]
29. High prevalence of metabolic syndrome in Takayasu arteritis: increased cardiovascular risk and lower adiponectin serum levels.
da Silva TF; Levy-Neto M; Bonfá E; Pereira RM
J Rheumatol; 2013 Nov; 40(11):1897-904. PubMed ID: 24037555
[TBL] [Abstract][Full Text] [Related]
30. Elevated chemokines concentration is associated with disease activity in Takayasu arteritis.
Dong H; Zhang Y; Zou Y; Chen Y; Yue J; Liu H; Jiang X
Cytokine; 2021 Jul; 143():155515. PubMed ID: 33849766
[TBL] [Abstract][Full Text] [Related]
31. Pentraxin-3 as a marker of disease activity in Takayasu arteritis.
Dagna L; Salvo F; Tiraboschi M; Bozzolo EP; Franchini S; Doglioni C; Manfredi AA; Baldissera E; Sabbadini MG
Ann Intern Med; 2011 Oct; 155(7):425-33. PubMed ID: 21969341
[TBL] [Abstract][Full Text] [Related]
32. Favourable pregnancy outcome in Takayasu arteritis: a single-centre experience.
Alpay-Kanitez N; Omma A; Erer B; Artim-Esen B; Gül A; Inanç M; Öcal L; Kamali S
Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-7-10. PubMed ID: 25236472
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-8 in Takayasu's arteritis: plasma levels and relationship with disease activity.
Tripathy NK; Sinha N; Nityanand S
Clin Exp Rheumatol; 2004; 22(6 Suppl 36):S27-30. PubMed ID: 15675131
[TBL] [Abstract][Full Text] [Related]
34. Takayasu arteritis in a 4-year-old girl: case report and brief overview of the pediatric literature.
Aypar E; Celebi-Tayfur A; Keser M; Odabaş D; Ozaltin F; Paksoy Y; Ozen S
Turk J Pediatr; 2012; 54(5):536-9. PubMed ID: 23427521
[TBL] [Abstract][Full Text] [Related]
35. Retrospective analysis of surgery versus endovascular intervention in Takayasu arteritis: a multicenter experience.
Saadoun D; Lambert M; Mirault T; Resche-Rigon M; Koskas F; Cluzel P; Mignot C; Schoindre Y; Chiche L; Hatron PY; Emmerich J; Cacoub P
Circulation; 2012 Feb; 125(6):813-9. PubMed ID: 22230484
[TBL] [Abstract][Full Text] [Related]
36. Resveratrol improves treatment outcome and laboratory parameters in patients with Takayasu arteritis: A randomized double-blind and placebo-controlled trial.
Shi G; Hua M; Xu Q; Ren T
Immunobiology; 2017 Feb; 222(2):164-168. PubMed ID: 27771172
[TBL] [Abstract][Full Text] [Related]
37. The association of red blood cell distribution width with anemia and inflammation in patients with Takayasu arteritis.
Liu Q; Dang AM; Chen BW; Lv NQ; Wang X; Zheng DY
Clin Chim Acta; 2015 Jan; 438():205-9. PubMed ID: 25173627
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis and assessment of Takayasu arteritis by multiple biomarkers.
Ishihara T; Haraguchi G; Tezuka D; Kamiishi T; Inagaki H; Isobe M
Circ J; 2013; 77(2):477-83. PubMed ID: 23100088
[TBL] [Abstract][Full Text] [Related]
39. Circulation levels of acute phase proteins in patients with Takayasu arteritis.
Ma J; Luo X; Wu Q; Chen Z; Kou L; Wang H
J Vasc Surg; 2010 Mar; 51(3):700-6. PubMed ID: 20100644
[TBL] [Abstract][Full Text] [Related]
40. [Takayasu's arteritis: underestimated cause of hypertension].
Cybulska I; Makowiecka-Cieśla M; Florczak E
Przegl Lek; 2001; 58(6):490-4. PubMed ID: 11816738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
